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Abstract
Elevated reactive oxygen species (ROS) in type 2 diabetes cause cellular damage in many
organs. Recently, the new class of glucose-lowering agents, SGLT-2 inhibitors, have been
shown to reduce the risk of developing diabetic complications; however, the mechanisms of
such beneficial effect are largely unknown. Here we aimed to investigate the effects of dapa-
gliflozin on cell proliferation and cell death under oxidative stress conditions and explore its
underlying mechanisms. Human proximal tubular cells (HK-2) were used. Cell growth and
death were monitored by cell counting, water-soluble tetrazolium-1 (WST-1) and lactate
dehydrogenase (LDH) assays, and flow cytometry. The cytosolic and mitochondrial (ROS)
production was measured using fluorescent probes (H2DCFDA and MitoSOX) under nor-
mal and oxidative stress conditions mimicked by addition of H2O2. Intracellular Ca
2+ dynam-
ics was monitored by FlexStation 3 using cell-permeable Ca2+ dye Fura-PE3/AM.
Dapagliflozin (0.1–10 μM) had no effect on HK-2 cell proliferation under normal conditions,
but an inhibitory effect was seen at an extreme high concentration (100 μM). However,
dapagliflozin at 0.1 to 5 μM showed remarkable protective effects against H2O2-induced cell
injury via increasing the viable cell number at phase G0/G1. The elevated cytosolic and
mitochondrial ROS under oxidative stress was significantly decreased by dapagliflozin.
Dapagliflozin increased the basal intracellular [Ca2+]i in proximal tubular cells, but did not
affect calcium release from endoplasmic reticulum and store-operated Ca2+ entry. The
H2O2-sensitive TRPM2 channel seemed to be involved in the Ca
2+ dynamics regulated by
dapagliflozin. However, dapagliflozin had no direct effects on ORAI1, ORAI3, TRPC4
and TRPC5 channels. Our results suggest that dapagliflozin shows anti-oxidative properties
by reducing cytosolic and mitochondrial ROS production and altering Ca2+ dynamics,
and thus exerts its protective effects against cell damage under oxidative stress
environment.
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Introduction
Dapagliflozin, also named Farxiga1, is a glucose-lowering therapeutic drug in the gliflozins
family [1,2]. It was developed by Bristol-Myers in partnership with AstraZeneca and approved
by FDA in 2014 [3]. Dapagliflozin blocks sodium glucose co-transporter 2 (SGLT-2) encoded
by SLC5A2 gene and thus inhibits the reabsorption of filtered glucose and sodium [4,5].
Recently, clinical trials have demonstrated that the inhibition of glucose uptake by proximal
tubules not only leads to lower glucose and glycated haemoglobin (HbA1c) levels in the blood
but also reduces the risk of developing later life diabetic complications, such as cardiovascular
events and diabetic kidney disease [2,6,7]. However, such beneficial effects and underlying
mechanisms of SGLT-2 inhibitors are largely unknown.
Oxidative stress is a main factor for causing cell injury in diabetes. There are very few
reports on the effect of dapagliflozin under oxidative stress conditions. In db/db mice, treat-
ment with dapagliflozin has been shown to reduce renal expression of some enzymes related
to reactive oxygen species (ROS) production and inflammation including NF-kB, Nox2, Nox4,
TGFβ1, monocyte chemoattractant protein-1 (MCP-1), osteopontin, intercellular adhesion
molecule-1 (ICAM-1), and myeloperoxidases (MPO) [8–10]. The reduction of ROS produc-
tion was also observed in rat heart after a 10-week treatment with the dapagliflozin analogue
empagliflozin [11]. These studies suggest that SGLT-2 inhibitors may have anti-oxidative
properties. In addition, dapagliflozin decreases the amplitude of intracellular Ca2+ transient
and L-type Ca2+ current in cardiac myocytes isolated from normal and diabetic rats [12], sug-
gesting it may affect intracellular calcium dynamics.
Here we have investigated the effects of dapagliflozin on cell growth and death under nor-
mal and oxidative stress environment that mimics diabetic conditions. The effects on cytosolic
and mitochondrial ROS production and intracellular [Ca2+]i, endoplasmic reticulum (ER) Ca
2
+ release, and store-operated Ca2+ influx have also been examined in the human proximal
tubular cells (HK-2), since this cell type has specific expression of the drug targeted protein
SGLT-2. The anti-oxidative stress effect we reported here could be an alternative mechanism
for the explanation of the beneficial effects of SGLT-2 inhibitors.
Materials and methods
Cell culture and transfection
The HK-2 cell line was purchased from LGC standards (Catalogue number CRL-2190, UK).
HK-2 cells were maintained in DMEM/F-12 medium with 5 mM glucose and supplemented
with 10% foetal calf serum (FCS), 10 mM HEPES and 100 units�mL-1 penicillin and
100 μg�mL-1 streptomycin. The function of reabsorption for the HK-2 cell line was character-
ized in our previous report [13]. The inducible TRPM2 cells were generated by transfection of
human TRPM2 gene (GenBank accession number BC112342) in pcDNA4/TO tetracycline-
regulatory vector into HEK-293 T-REx cells (Invitrogen, Paisley, UK). The TRPM2 cells were
cultured and maintained using standard DMEM/F-12 medium. The expression of TRPM2
was induced by tetracycline (1 μg�mL-1) and the function was characterized as we described
previously [14]. All the cell cultures were maintained at 37˚C under 95% air and 5% CO2 with-
out mycoplasma contamination.
Cell apoptosis, necrosis and proliferation assays
Apoptosis was measured by direct cell counting after Hoechst 33342 and propidium iodide
nuclear staining. HK-2 cells were fixed with 4% paraformaldehyde in 100 mM phosphate
buffer solution (22.6 mM NaH2PO4 and 77.4 mM Na2HPO4), washed out with PBS, and
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incubated with Hoechst 33342 (1 μM) and propidium iodide (15 μM) for 30 min in the dark.
The cells were washed with PBS twice and the nuclear staining was photographed using a fluo-
rescent microscopy. The apoptotic cells with condensed nuclear staining were counted using
CellC software. For necrotic cell death, the activity of lactate dehydrogenase (LDH) in the cul-
ture medium that released from the cytosol was determined using a Cytotoxicity Detection Kit
(Roche) with similar procedures in our previous report [15]. Cell proliferation was determined
using a water-soluble tetrazolium-1 (WST-1) assay in which tetrazolium salts are cleaved by
mitochondrial dehydrogenase to form formazan in viable cells [16]. The absorbance for WST-
1 and LDH assays was measured using a spectrophotometer.
Fluorescence-activated cell sorting (FACS)
The HK-2 cells were seeded into a 6-cm petri dish at a confluence of 5000 cells/mL and incu-
bated in a humidified atmosphere of 5% CO2 and 95% air at 37˚C for 24 hours. The cells were
pre-treated with different concentrations of dapagliflozin for 2 hours before addition of
200 μM H2O2, followed by a 24-hour incubation with dapagliflozin or/and H2O2. The cells
were trypsinised with 0.25% trypsin-EDTA and centrifuged twice with PBS in FACS tubes at
300 g for 5 minutes. The PBS was then removed and 200 μL of 10 μg/mL propidium iodide
was added to all the tubes and incubated for 15 minutes before mounting for FACS detection.
The cell cycle was analysed using CellQuest software and all groups were set in triplicates.
Cytosolic and mitochondrial ROS assays
The cytosolic ROS fluorescent indicator H2DCFDA was used to monitor ROS production.
Briefly, HK-2 cells were seeded into a 96-well plate at a confluence of 6 ×104 cells per well and
incubated for 24 hours. The cells were washed twice with warm PBS and loaded with
H2DCFDA dye at a final concentration of 2 μM in standard bath solution. The standard bath
solution contained (mM): 130 NaCl, 5 KCl, 8 D-glucose, 10 HEPES, 1.2 MgCl2, and 1.5 CaCl2,
and the pH was adjusted to 7.4 with NaOH. After incubation for 45 minutes at 37˚C in the
dye, cells were washed with standard bath solution and dapagliflozin at different concentra-
tions was added into the wells to a final volume of 200 μL. The plate was then placed in FlexSta-
tion 3 (Molecular Device, USA) and the fluorescence intensity was read at excitation/emission
wavelength of 492/520 nm using a kinetics protocol. The protocol was set to automatically add
10 μL of 2 mM H2O2 solution at a time point of 300 seconds to give a final concentration of
200 μM H2O2.
For mitochondrial ROS assay, the mitochondrial ROS indicator, MitoSOX, was loaded at a
concentration of 5 μM in PBS. MitoSOX red is a cationic derivative of dihydroethidium which
enters live cells and specifically intercalates with mitochondrial DNA and results in red fluo-
rescence. The successful loading of MitoSOX was examined using a fluorescent microscopy
and the cells were then washed twice with standard bath solution. Dapagliflozin at different
concentrations was added to the cells for 3–5 min prior to the experiment. The plate was then
placed in FlexStation 3 and fluorescence was measured at excitation/emission wavelength of
510/580 nm.
[Ca2+]i measurement
Cells were pre-incubated with 2 μM Fura-PE3/AM at 37˚C for 30 min in Ca2+-free bath solu-
tion (mM):130 NaCl, 5 KCl, 1.2 MgCl2, 10 HEPES, 8 D-glucose, and 0.4 EGTA, followed by a
20-min wash period in the standard bath solution at room temperature. The ratio of Ca2+ dye
fluorescence (F340/F380) was measured using FlexStation 3. Thapsigargin (TG, 1μM) was used
to block SERCA in the ER to cause ER Ca2+ release signal in Ca2+-free bath solution. The
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store-operated Ca2+ entry (SOCE) was measured by addition of 1.5 mM Ca2+ after the ER Ca2
+ store depletion by TG.
Electrophysiology
The whole-cell patch clamp procedure is similar to our previous report [17]. Briefly, electrical
signal was amplified with an Axopatch 200B patch clamp amplifier and controlled with
pClamp software 10. A 1-s ramp voltage protocol from –100 mV to +100 mV was applied at a
frequency of 0.2 Hz from a holding potential of 0 mV. Signals were sampled at 1 kHz. The
glass microelectrode with a resistance of 3–5 MO was used. The pipette solution contained (in
mM): 115 CsCl, 10 EGTA, 2 MgCl2, 10 HEPES and 5.7 CaCl2, pH was adjusted to 7.2 with
CsOH and osmolarity was adjusted to *290 mOsm with mannitol, and the calculated free
Ca2+ was 200 nM. ADP-ribose (0.5 mM) was added in the pipette solution to activate TRPM2.
The cells were perfused with standard bath solution during whole-cell patch recording. The
experiment was performed at room temperature (25˚C).
RT-PCR
Total RNA was extracted from the HK-2 cells using TRI reagent (Sigma). The RNA was
reverse transcribed with moloney murine leukaemia virus reverse transcriptase (RT) using
random primers and oligo dT primers (Promega). Quantitative RT-PCR was performed using
StepOne™ Real-Time PCR System (Applied Biosystems, UK). The primer set was designed
across introns to avoid genomic DNA contamination and synthesized by Sigma-Genosys. The
primer sequences were: SGLT-1 (ACCTTTCCCTTCTGTCCCTG and CATGATCACCGTCTG
CAAGG); SGLT-2-primer set 1 (GACATGTTCTCCGGAGCTGT and GCTCCCAGGTATTTGTC
GAA); SGLT-2-primer set 2 (TCACGATGCCACAGTACC and TAGATGTTCCAGCCCAGAGC);
β-actin (ACAGAGCCTCGCCTTTGC and GGAATCCTTCTGACCCATGC). Each reaction volume
was 10 μl, which contained 1 × SYBR Green PCR master mix (Applied Biosystems), 5 μl of
cDNA, 0.75 μl of 300 nM forward primer, and 0.75 μl of 300 nM reverse primer. Human β-
actin was used as an internal standard for control. The PCR cycle was programmed as an initial
cycle of 50 ˚C for 2 min, followed by 95 ˚C for 10 min, then 50 repeated cycles of 95 ˚C for 15 s
denaturation and 54 ˚C annealing temperature for 30 s, and primer extension at 72 ˚C for 30 s.
The PCR products were examined by electrophoresis on 2% agarose gels.
Chemicals and reagents
All general salts and reagents were from Sigma (UK). Dapagliflozin, hydrogen peroxide
(H2O2), 2-aminoethoxydiphenyl borate (2-APB), tetracycline, thapsigargin, propidium iodide,
Hoechst 33342 and FCCP (carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone) were pur-
chased from Sigma-Aldrich. MitoSOX and H2DCFDA were purchased from Thermo Fisher
Scientific UK. Fura-PE3/AM was purchased from Invitrogen (UK). Dapagliflozin (100 mM),
Fura-PE3/AM (1 mM), thapsigargin (1 mM) and 2-APB (100 mM) were made up as stock
solutions in 100% dimethyl sulphoxide (DMSO).
Statistics
Data are expressed as mean ± SEM. Where n is the number of wells for FlexStation experi-
ments or cell number for electrophysiological recordings. Mean data were compared using
paired t test for the results before and after treatment, or unpaired t test for two group compar-
ison. ANOVA with Bonferroni’s post-hoc analysis was used for comparing more than two
groups with significance indicated if P<0.05.
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Results
Expression of SGLT isoforms in HK-2 cells
HK-2 cell line is an immortalized proximal tubule epithelial cell line derived from normal
adult human kidney [13,18]. To confirm the phenotype of human proximal tubular cell line,
the expression of sodium glucose co-transporter-1 (SGLT-1) and -2 (SGLT-2) was examined
using RT-PCR. Two primer sets across introns were used for SGLT-2 and β-actin was set as a
positive control, the bands for SGLT-2 were much stronger than that for SGLT-1 and β-actin
(Fig 1), suggesting that SGLT-2 is highly expressed in the proximal tubular cell line, which also
confirms the specific cell marker for the proximal tubular cells used in the study.
Oxidative stress-induced cell injury
Cell growth and death were examined under oxidative stress conditions mimicked by addition
of H2O2. Cell proliferation was monitored by WST-1 assay, which is proportional to the num-
ber of viable cells. HK-2 cells were incubated with different concentrations of H2O2 for 24
hours and the cell proliferation was significantly decreased in a concentration-dependent man-
ner (Fig 2A). The half-maximal inhibitory concentration (IC50) was calculated according to the
normalised dose response curve with an IC50 of 115 μM and a slope factor of 1.74 (Fig 2B).
The effect of H2O2 on HK-2 cell death was determined by LDH assay after incubation with
different concentrations of H2O2 ranging from 0 to 4000 μM for 24 hours (Fig 2C). The LDH
activity in the medium increased in a concentration-dependent manner. The IC50 was 199 μM
with a slope factor (p) of 0.007 (Fig 2D), suggesting that H2O2 significantly induced cell death.
To further investigate H2O2-induced cell death, we examined the apoptotic cell death using
nuclear staining with propidium iodide and Hoechst 33342. After 24 hours incubation with
200 μM H2O2, the apoptotic cell number was counted after taking pictures using a fluorescent
microscopy. The HK-2 cells treated with H2O2 showed a significant increase of apoptotic cell
death (Fig 2C and 2D). These results suggest that H2O2 is a useful agent to induce human
proximal tubular cell injury to mimic oxidative stress condition.
Effects of dapagliflozin on cell proliferation and death under normal and
oxidative stress conditions
To investigate the effects of dapagliflozin on HK-2 cell proliferation under normal and oxida-
tive stress conditions, cells were treated with different concentrations of dapagliflozin for
24-hour with or without incubation with 200 μM H2O2. H2O2 at 200 μM was used because this
concentration near the IC50 can mimic oxidative stress to cause cell growth inhibition and cell
death. Under normal cell culture condition, dapagliflozin itself did not affect cell proliferation
except the highest concentration (100 μM) that showed a significant decrease in cell prolifera-
tion, suggesting a potential cytotoxic effect at the very high concentration. However, dapagli-
flozin at concentrations between 0.1 and 10 μM showed a significant increase in proliferation
under the oxidative stress condition by adding 200 μM H2O2. Dapagliflozin at 0.1 μM showed
the maximum protective effect against the H2O2-induced inhibition of cell proliferation.
The effect of dapagliflozin on cell death was also examined. In normal condition, dapagliflo-
zin at 0.1, 1 and 5 μM did not show any significant effects on LDH release from the HK-2 cells,
but higher concentrations (10 and 100 μM) showed a significant increase compared to the con-
trol (Fig 3B), suggesting that the drug at high concentrations can cause cell injury, which
should be alerted in clinic practice. In the cells treated with H2O2, dapagliflozin at 0.1, 1, and
5 μM showed a significant reduction in LDH release compared to the control. The greatest
protection occurred at the concentration of 0.1 μM (Fig 3B). These results suggested that
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dapagliflozin is a potent agent in the protection of oxidative stress-induced cell death in proxi-
mal tubular cells. Similar to cell proliferation, too high concentration of dapagliflozin
(100 μM) did not show any protection but damage the cells.
The apoptotic cells were counted using nuclear staining methods with propidium iodide
and Hoechst 33342. Dapagliflozin at 0.1 μM significantly reduced the percentage of apoptotic
Fig 1. The mRNAs of SGLT-1 and SGLT-2 were detected in HK-2 cells by RT-PCR. The β-actin was set as positive
control. Two primer sets (P1 and P2) were used for SGLT-2. The product size for β-actin, SGLT-1, SGLT-2 (P1) and
SGLT-2 (P2) is 203 bp, 211 bp, 236 bp, and 159 bp, respectively. 2% agarose gel was used (Also see full length gel in S1
Fig).
https://doi.org/10.1371/journal.pone.0247234.g001
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cell death (Fig 3C and 3D), which further supports the protective effects of dapagliflozin
against H2O2-induced cell death.
Cell cycle response to H2O2 and the effect of dapagliflozin
The effects of dapagliflozin on H2O2-induced cell cycle arrest have been examined. The HK-2
cells treated with different concentrations of dapagliflozin with or without H2O2 and the effect
on cell cycle was analysed by FACS after staining with propidium iodide (Fig 4A). Cells treated
with 200 μM H2O2 showed a significant increase of cells arrested in the G2/M phase (~ 33%)
and in the S phase (6%) compared to the non-treated control, suggesting that the cell cycle of
HK-2 cells is arrested by the oxidative stress condition. In the group without H2O2 treatment,
dapagliflozin did not significantly alter the cell cycle except the high concentration group
(10 μM) with an increased percentage of cells in S phase, reflecting an active repair response
(Fig 4B). In cells treated with both dapagliflozin and 200 μM H2O2, dapagliflozin at 0.01 and
0.1 μM significantly increased the percentage of cells in G0/G1 phase and decreased the per-
centage of cells in G2/M phase. Dapagliflozin at 0.1 μM also reduced the percentage of cells in
Fig 2. Cell proliferation and death under H2O2-induced oxidative stress conditions. The proliferation of HK-2 cells was assayed with WST-1 reagents after a 24-hour
incubation with different concentrations of H2O2. The absorbance was measured at a wavelength of 450 nm with a reference wavelength of 650 nm. A, Mean ± SEM
data (n = 8 for each group). B, The normalised dose-response data was fitted with the equation: y = A2 + (A1-A2)/(1 + (x/x0)^p), and the IC50 was 114.9 μM. C, The
cytotoxicity of HK-2 cells was assayed using LDH reagents after a 24-hour incubation with H2O2, and the absorbance was measured at a wavelength of 490 nm and a
reference wavelength of 680 nm. D, The dose–response curve showed an IC50 of 199.4 μM for cytotoxicity (n = 8 for each group, ANOVA with Bonferroni post hoc test
was used for group comparison). E, Examples of Hoechst 33342 (Hoechst) and propidium iodide (PI) nuclear staining. Scale bar = 100 μm. F, Mean ± SEM data for
apoptotic cell counting (n = 6 for each group). ��� P<0.001.
https://doi.org/10.1371/journal.pone.0247234.g002
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the S phase (Fig 4B). These results suggest that the alteration of cell cycle by oxidative stress
can be prevented by dapagliflozin.
Dapagliflozin prevents H2O2-induced cytosolic ROS production
The cytosolic ROS production was real-time monitored using FlexStation 3 in normal and oxi-
dative stress conditions using fluorescent ROS indicator H2DCFDA. After adding 200 μM
H2O2 to the cells, the fluorescence intensity gradually increased and the slope was much bigger
than the control group without H2O2 (Fig 5A and 5B), suggesting that the ROS production is
higher in the oxidative stress condition. This result is consistent with the previous report [19],
suggesting that H2O2 stimulates cytosolic ROS production.
To investigate the effects of dapagliflozin on ROS production, HK-2 cells were incubated
with different concentrations of dapagliflozin. The fluorescence was gradually increased as the
incubation time increasing, however there was no statistical difference compared to the con-
trol (Fig 5C and 5D), suggesting that dapagliflozin (0.1–10 μM) did not affect cytosolic ROS
production in normal condition. However, under oxidative stress conditions, dapagliflozin at
0.1 μM showed a significant reduction of ROS production compared to the H2O2 control,
Fig 3. Effects of dapagliflozin on cell growth and death under normal and H2O2-induced oxidative stress
conditions. A, Effect on cell proliferation under normal and oxidative stress conditions mimicked with 200 μM H2O2.
Cell proliferation was assayed with WST-1 reagents after incubation with dapagliflozin for 24 hours. The absorbance
was measured (n = 8 for each group). B, Cytotoxicity was assayed with LDH reagents after incubation with
dapagliflozin for 24 hours, with or without 200 μM H2O2 (n = 8 for each group). The absorbance was measured at a
wavelength of 490 nm and a reference wavelength of 680 nm. In A and B, ��� P<0.001 is for the comparison with
control, and ## P<0.01 and ### P<0.001 for the comparison with H2O2 control group without dapagliflozin. One-way
ANOVA with Bonferroni post hoc test was used for group comparisons. C, Examples of nuclear staining with
propidium iodide (PI) and Hoechst 33342 (Hoechst). Scale bar = 100 μm. D, Mean ± SEM data for the percentage of
apoptotic cells in the group of H2O2 (200 μM) and H2O2 (200 μM) plus dapagliflozin (0.1 μM). (n = 6 for each group,
��� P<0.001 by unpaired t-test).
https://doi.org/10.1371/journal.pone.0247234.g003
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reflecting its antioxidative properties. Nevertheless, dapagliflozin at 1 and 10 μM did not
reduce ROS (Fig 5E and 5F), suggesting the beneficial effect of dapagliflozin is associated with
the concentrations used.
Mitochondrial ROS production reduced by dapagliflozin
To observe the effects on mitochondrial ROS, MitoSOX was used as mitochondrial superoxide
indicator. Cells were incubated with MitoSOX (5 μM) for 30 min and the red fluorescence in
mitochondria was evident (Fig 6A). The intensity of MitoSOX was significantly increased after
incubation with a mitochondrial oxidative phosphorylation uncoupler FCCP (Fig 6B), sug-
gesting that MitoSOX is specific for mitochondrial ROS detection. H2O2 at 200 μM also signif-
icantly increased mitochondrial ROS production (Fig 6C and 6D). These data suggest that
mitochondrial ROS production was enhanced in the cells under oxidative stress conditions.
The effects of dapagliflozin on mitochondrial ROS were examined in normal and oxidative
stress conditions. MitoSOX fluorescence intensity was not changed significantly compared to
the control, suggesting that dapagliflozin did not affect mitochondrial ROS production in nor-
mal condition. Under oxidative stress condition dapagliflozin at 0.1 μM significantly decreased
the ROS production in the mitochondria (Fig 6G and 6H), suggesting its preventive effect on
mitochondrial ROS production. However, higher concentrations (1, 10 μM) of dapagliflozin
did not show any protection.
Intracellular calcium dynamics modulated by dapagliflozin
The interplay of ROS and intracellular [Ca2+]i is an important cellular process for regulating
mitochondrial function, gene expression and apoptosis [20], therefore the [Ca2+]i was
Fig 4. Cell cycle response to oxidative stress and the effect of dapagliflozin. A, Human proximal tubular cells (HK-2) were cultured in 6-cm petri dishes and the
oxidative stress was induced with 200 μM H2O2 for 24 hours. The histogram examples of the cells stained with propidium iodide with or without 0.1 μM dapagliflozin
(Dapa). B, Cell cycle was quantified by FACS and mean ± SEM data were presented (n = 3). One-way ANOVA with Bonferroni post hoc test was used for group
comparison. �� P<0.01 and ��� P<0.001 for G0/G1 phase comparison; ΔΔΔ P<0.001 for S phase comparison; and ## P<0.01 and ### P<0.001 for G2/M phase
comparison.
https://doi.org/10.1371/journal.pone.0247234.g004
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measured by FlexStation 3 using the Ca2+ dye Fura-PE3/AM. The HK-2 cells were treated with
different concentrations of dapagliflozin and the basal Ca2+ fluorescence was determined
under normal bath solution. Dapagliflozin at concentrations ranging from 0.01 μM to 10 μM
increased basal intracellular calcium level (Fig 7A). To explore the underlying mechanisms,
the ER calcium release and SOCE were examined, and dapagliflozin had no significant effects
on TG-induced Ca2+ release and SOCE (Fig 7B and 7C). We also examined the effect on
H2O2-sensitive cation channel TRPM2. Interestingly, pre-incubation with dapagliflozin
Fig 5. Cytosolic ROS production under oxidative stress and the protection by dapagliflozin. HK-2 cells were
loaded with cytosolic ROS indicator, H2DCFDA (2 μM) and the fluorescence intensity was dynamically monitored
using FlexStation at an excitation wavelength of 492 nm and an emission wavelength of 520 nm. Reads were sampled
every 60 seconds. A. The time course of fluorescence intensity in control and H2O2-treated groups. B, Change of
cytosolic ROS fluorescence in 60 min for the control (without H2O2) and H2O2 groups (n = 5, ��� P<0.001). C, Effects
of dapagliflozin (Dapa) on cytosolic ROS production under normal conditions. D, Mean ± SEM data for the change of
fluorescence in HK-2 cells within 60 min. E, Time course of cytosolic ROS indicator fluorescence for the cells treated
with H2O2 (200 μM) and different concentrations of dapagliflozin. F, Mean ± SEM data for the delta fluorescence
changes in 60 min (n = 5 for each concentration). One-way ANOVA with Bonferroni post hoc test was used. ��
P<0.01.
https://doi.org/10.1371/journal.pone.0247234.g005
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significantly enhanced the Ca2+ influx in the Tet-induced TRPM2 cells with a unique second
phase of activation, but no such phenomena in the non-induced control cells (Fig 7D). This
delayed activation could be due to an indirect effect, since dapagliflozin had no direct effect on
the channel per se using whole-cell patch clamp recording with intracellular ADP-ribose acti-
vator (Fig 7F). Dapagliflozin had no effects on TRPC4, TRPC5, ORAI1 and ORAI3 (Fig 8),
and those channels are also expressed in the human proximal tubular cells [13,21–24] and
have redox-sensitivity [25–27].
Discussion
Our results show that dapagliflozin displays a significant protective effect against oxidative
stress-induced cell injury in HK-2 cells. The elevated cytosolic ROS and mitochondrial ROS
production under oxidative stress conditions is reduced by pre-treatment with dapagliflozin.
Dapagliflozin also increases basal intracellular Ca2+ level and interferences with intracellular
Ca2+ dynamics, which might be mediated by an indirect effect via the H2O2-sensentive
TRPM2 channels. Dapagliflozin has no effects on ER calcium release, SOCE, ORAI channels,
TRPC4, and TRPC5 channels. These findings give a new insight into the pharmacology of
SGLT-2 inhibitors.
Fig 6. Mitochondrial ROS detected by MitoSOX and the effect of dapagliflozin. A. HK-2 cells loaded with mitochondrial ROS indicator MitoSOX (5 μM)
and measured by FlexStation 3 at the excitation wavelength of 510 nm and emission wavelength of 580 nm and the kinetics was sampled every 60 sec. The time
course for the cells treated with FCCP (50 μM) or without FCCP (control). Example of MitoSOX (Red) loading was shown in the inset. B. Mean data for
MitoSOX intensity change at the time point of 60 min in both control and FCCP groups (n = 8 for each group, ��� P<0.001). C, Time course for MitoSOX
fluorescence in the cells treated with or without (control) 200 μM H2O2. D, Mean ± SEM data (n = 7 for each group, ��� P<0.001 assessed by unpaired t-test).
E, Effect of dapagliflozin (Dapa) on the intensity of mitochondrial ROS fluorescence in HK-2 cells under normal conditions. F, Mean ± SEM data (n = 7 for
each group). G, Effect of dapagliflozin under H2O2-induced oxidative stress conditions. H, Mean ± SEM data for the delta changes of mitochondrial MitoSOX
intensity within 60 min treatment (n = 7 for each group). One-way ANOVA with Bonferroni post hoc test was used, �� P<0.01.
https://doi.org/10.1371/journal.pone.0247234.g006
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Hydrogen peroxide has been used in vitro cell models to mimic oxidative stress conditions.
The concentration at 100–500 μM has been used in different cell types to induce apoptotic cell
death, necrosis and the inhibition of cell proliferation [15,30]. We have examined the dose
response of H2O2 in the HK-2 cells and found that the concentration near IC50 (200 μM) can
successfully mimic oxidative stress condition. Dapagliflozin at 0.1 to 5 μM shows a significant
protective effect against oxidative stress-induced cell injury. Both H2O2-induced apoptosis and
cell growth inhibition are alleviated by dapagliflozin. However high concentrations of dapagli-
flozin (more than 10 μM) may cause cytotoxicity. Based on human pharmacokinetics data, the
maximum therapeutic plasma concentration of dapagliflozin (Cmax) is 158 ng/ml (~0.39 μM)
[3] and the extreme high Cmax is 1000 ng/ml (~2.44 μM) [31], therefore the protective effect of
dapagliflozin at 0.1 to 1 μM should be considered as a therapeutic effect.
The real-time monitoring of fluorescence intensity of specific ROS indicators allows us to
accurately detect cytosolic ROS or mitochondria ROS production. The control group and test
groups were run in parallel in same plate, which produces more reliable data for comparison.
We found that the cytosolic ROS is enhanced under oxidative stress and dapagliflozin at
0.1 μM reduced the enhanced ROS production. This finding is consistent with the in vivo
study in Akita mice kidney and the in vitro study using cultured murine proximal tubular epi-
thelial cells under high glucose condition [10,32]. We have also examined the mitochondrial
ROS production using MitoSOX™ red. MitoSOX is cell permeable and rapidly oxidized by
superoxide but not by other ROS and reactive nitrogen species (RNS). In order to confirm the
dye specificity, the mitochondrial chain uncoupler FCCP was used as a positive control in this
study, which has been reported to increase MitoSOX fluorescence intensity [33]. Our data
show that the prevention of ROS production by dapagliflozin (0.1 μM) is seen in the oxidative
stress condition, but not in the normal condition. Too high concentrations (� 10 μM) of
Fig 7. Effect of dapagliflozin on basal [Ca2+]i and Ca
2+ influx in HK-2-cells. HK-2 cells were seeded at a confluence
of 6×104 cells/well and incubated for 12 hours before loading with Fura-PE3/AM (1 μM). The ratio (F340/F380) was
measured using FlexStation 3. A, Mean ± SEM data for the basal Ca2+ level (n = 7 for each group). B, Effect on
thapsigargin (TG, 1 μM) induced Ca2+ release and store-operated Ca2+ entry (SOCE) after refilling with 1.5 mM Ca2+.
C, Mean ± SEM data for (B) (n = 7). D, HEK293 T-REx cells over-expressing with human TRPM2 and the activation
by 1 mM H2O2 (n = 8). E, Dapagliflozin (Dapa) altered intracellular Ca2+ dynamics related to the TRPM2 channels. F,
No direct effect on TRPM2 channel activated by ADP-ribose (0.5 mM). G, Mean ± SEM data for (F) (n = 4).
https://doi.org/10.1371/journal.pone.0247234.g007
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dapagliflozin have no protective effects rather than cytotoxicity. It is unclear how dapagliflozin
alters the mitochondrial activity. Dapagliflozin may influence on Bcl2 or Bax expression [34].
Dapagliflozin may also cause a modest inhibition of mitochondrial complex I and activate
AMPK [35]. The anti-oxidant capacity of gliflozin family has been examined using an oxygen
radical absorbance capacity assay, dapagliflozin itself has less anti-oxidant capacity by its
chemical structure comparing with remogliflozin and canagliflozin [36], but strong antioxi-
dant effect was seen in cells, suggesting the effect is due to a biological process.
Oxidative stress and high glucose in diabetes are closely related to intracellular Ca2+ dynam-
ics, calcium channels and apoptotic protein regulators [13,37–39]. Therefore, we have exam-
ined the Ca2+ release, Ca2+ influx and some Ca2+ channels. Dapagliflozin slightly increases the
basal Ca2+ level in HK-2 cells, but does not change Ca2+ release and store-operated Ca2+ influx.
However, the Ca2+ influx via TRPM2 seems to be facilitated by dapagliflozin when H2O2 is
applied, which could be due to the dynamic change of intracellular Ca2+ homeostasis and then
affect TRPM2 channel sensitivity to [Ca2+]i [38]. Nevertheless, the channel itself did not show
any direct response to dapagliflozin in the patch clamp experiments, where the intracellular
Ca2+ level was clamped with the buffered pipette solution. Dapagliflozin may have a differen-
tial effect from other SGLT-2 inhibitors, since empagliflozin and canagliflozin can cause coro-
nary vasodilation, but dapagliflozin cannot [40]. In addition, the inhibition of Na+-H+
exchanger (NHX) by SGLT-2 inhibitors may also affect the mitochondrial and cytosol Ca2+
homeostasis [12,41,42]. SGLT-2 is almost exclusively expressed in the kidney proximal tubules
Fig 8. No effect of dapagliflozin on ORAI1, ORAI3, TRPC4 and TRPC5 currents. Whole-cell patch recording was
performed using HEK293 T-REx cells overexpressing ORAI or TRPC channels. The detail procedures are similar to
our previous reports [13,27–29]. A, Example of ORAI1 current recorded in the HEK293 T-REx cells expressing
ORAI1-mCherry. The current was induced by thapsigargin (1 μM) in the pipette solution. Dapagliflozin (Dapa)
showed no obvious effect on the current, but diethylstilbestrol (DES) as a positive control blocker significantly
inhibited the ORAI1 current. B, Example of ORAI3 current induced by 2-APB (100 μM) and the effect of Dapa (1,
10 μM). C, Example of TRPC4 current in the presence of activator Gd3+ (20 μM) and the effect of Dapa (10 μM).
2-APB (100 μM) was added as a positive control (inhibitor). D, TRPC5 was induced by Gd3+ (20 μM) and the effect of
ML204 (10 μM) and Dapa (10 μM). The IV curves were shown as insets in each panel. N = 3–5 for each channel
current recorded by whole-cell patch.
https://doi.org/10.1371/journal.pone.0247234.g008
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although it has also been reported in other organs, such as pancreatic alpha cells [43], therefore
it could be difficult to extend the concept from the cell types with low SGLT-2 and high L-type
Ca2+ channels expression, such as cardiac myocytes, to the HK-2 cells with high SGLT-2
expression and no L-type Ca2+ channels, since dapagliflozin inhibits L-type channel expression
in the heart [44].
In conclusion, dapagliflozin displays a significant protective effect against oxidative stress
induced proximal tubular cell injury. This protective effect is mediated by the reduction of
cytosolic ROS and mitochondrial superoxide ROS production. Dapagliflozin also alters the
dynamics of Ca2+ influx via the oxidative-sensitive TRPM2 Ca2+ channels. The antioxidative
effect could be a new alternative explanation for the beneficial effects of dapagliflozin.
Supporting information
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